𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic counseling of adults with Williams syndrome: A first study

✍ Scribed by Katrina Farwig; Amanda G. Harmon; Kristina M. Fontana; Carolyn B. Mervis; Colleen A. Morris


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
106 KB
Volume
154C
Category
Article
ISSN
1552-4868

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Genetic counseling in Angelman syndrome:
✍ Stalker, Heather J.; Williams, Charles A. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 30 KB πŸ‘ 2 views

The causal heterogeneity of Angelman syndrome (AS) makes providing information regarding recurrence risk both important and challenging, and may have a dramatic impact on reproductive decision-making for the nuclear and extended family. Most cases of AS result from typical large de novo deletions of

Diagnosis and management of medical prob
✍ Barbara R. Pober; Colleen A. Morris πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 1 views

## Abstract Williams–Beuren syndrome (WBS) is a multi‐system disorder that requires ongoing management by a primary care physician familiar with the natural history and common medical problems associated with the condition. Some abnormalities are unique to WBS, such as the elastin arteriopathy that

Genetic and hematological studies in a g
✍ Lee, K.; PrΓ©hu, C.; MΓ©rault, G.; KΓ©clard, L.; Roudot-Thoraval, F.; Bachir, D.; W πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

The clinical and biological heterogeneity of sickle cell hemoglobin (Hb) C disease (SC disease) is similar to sickle cell anemia, but has a much milder course. The effect of genetic factors such as ␣ thalassemia or ␀-globin gene haplotype has been analyzed in a limited number of cases. In this work,

A pilot study of interleukin-2 for adult
✍ Jorge E. Cortes; Hagop M. Kantarjian; Susan O'Brien; Francis Giles; Michael J. K πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 2 views

## BACKGROUND. Interleukin-2 (IL-2) has immunomodulatory effects, including stimulating the activity of cytotoxic T cells and natural killer cells, and inducing the generation of lymphokine-activated killer cells. The authors investigated whether IL-2 may improve the duration of complete remission